Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Woohyung Lee"'
Autor:
Sora Kang, Changhoon Yoo, So Heun Lee, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Bong Jun Kwak, Sarang Hong, Heung-Moon Chang, Baek-Yeol Ryoo, Kyu-pyo Kim, Song Cheol Kim
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Adjuvant chemotherapy is the standard treatment after curative-intent surgery for pancreatic ductal adenocarcinoma (PDAC). The phase-3 ESPAC-4 trial demonstrated significantly improved overall survival (OS) with Gemcitabine plus capecitab
Externí odkaz:
https://doaj.org/article/e942281ca3ca4e8a8b4a6d4a9d6b8278
Autor:
Changhoon Yoo, Inhwan Hwang, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jae Ho Byun, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Heung-Moon Chang, Kyu-pyo Kim, Song Cheol Kim, Baek-Yeol Ryoo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Despite the scarcity of data based on randomized trials, FOLFIRINOX is widely used in the management of borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). We investigated the clinica
Externí odkaz:
https://doaj.org/article/874e49da26b34095a1293afc4559a313
Autor:
Sora, Kang, Changhoon, Yoo, So Heun, Lee, Dongwook, Oh, Tae Jun, Song, Sang Soo, Lee, Jae Ho, Jeong, Do Hyun, Park, Dong Wan, Seo, Jin-Hong, Park, Dae Wook, Hwang, Ki Byung, Song, Jae Hoon, Lee, Woohyung, Lee, Bong Jun, Kwak, Sarang, Hong, Heung-Moon, Chang, Baek-Yeol, Ryoo, Kyu-Pyo, Kim, Song Cheol, Kim
Publikováno v:
Therapeutic advances in medical oncology. 14
Adjuvant chemotherapy is the standard treatment after curative-intent surgery for pancreatic ductal adenocarcinoma (PDAC). The phase-3 ESPAC-4 trial demonstrated significantly improved overall survival (OS) with Gemcitabine plus capecitabine (GemCap)
Autor:
Baek-Yeol Ryoo, Kyu-Pyo Kim, Dong Wan Seo, Sang Soo Lee, Jae Hoon Lee, Sung Koo Lee, Inhwan Hwang, Jae Ho Byun, Heung-Moon Chang, Woohyung Lee, Myung-Hwan Kim, Song Cheol Kim, Tae Jun Song, Do Hyun Park, Dae Wook Hwang, Jin-Hong Park, Changhoon Yoo, Ki Byung Song, Jae Ho Jeong
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Despite the scarcity of data based on randomized trials, FOLFIRINOX is widely used in the management of borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). We investigated the clinica
Autor:
Sora Kang, Changhoon Yoo, So Heun Lee, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Jae Ho Jeong, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Bong Jun Kwak, Sarang Hong, Heung-Moon Chang, Baek-Yeol Ryoo, Kyu-pyo Kim, Song Cheol Kim
Publikováno v:
Therapeutic Advances in Medical Oncology. 14:175883592210971
Background: Adjuvant chemotherapy is the standard treatment after curative-intent surgery for pancreatic ductal adenocarcinoma (PDAC). The phase-3 ESPAC-4 trial demonstrated significantly improved overall survival (OS) with Gemcitabine plus capecitab